Patent · US Active

Compounds

US9902715B2 · kind B2 · utility

0Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 26, 2015
Grant dateFeb 27, 2018
Priority date
Expiry dateMay 26, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.